Table 7.
False positive reporting probability values for Associations between the combined genotypes of MGMT and SCCHN risk
Combined Genotypes | Positive OR and 95% CIa | Pb | Statistical Powerc | Prior probability |
||||
---|---|---|---|---|---|---|---|---|
0.25 | 0.1 | 0.01 | 0.001 | 0.0001 | ||||
0-2 risk genotypes vs. 3-4 risk genotypes | ||||||||
All subjects | 1.27 (1.06-1.53) | 0.012 | 0.958 | 0.036 | 0.101 | 0.553 | 0.926 | 0.992 |
Ever smoker | 1.26 (1.01-1.57) | 0.037 | 0.937 | 0.106 | 0.262 | 0.796 | 0.975 | 0.997 |
Ever drinking | 1.28 (1.03-1.59) | 0.025 | 0.923 | 0.075 | 0.196 | 0.728 | 0.964 | 0.996 |
Oropharynx | 1.44 (1.12-1.85) | 0.004 | 0.615 | 0.019 | 0.055 | 0.392 | 0.867 | 0.985 |
Orophasyngeal Cancer | ||||||||
Involvement of regional lymph nodes(N1-3) | 1.51 (1.16-1.98) | 0.003 | 0.499 | 0.018 | 0.051 | 0.373 | 0.857 | 0.984 |
Tumor stage T1-2 | 1.73 (1.26-2.37) | 0.001 | 0.227 | 0.013 | 0.038 | 0.304 | 0.815 | 0.978 |
The crude OR.
The omnibus chi-square test of the combination genotype distributions.
Calculated using study subjects to detect an OR of 1.5 with the common combined genotype used as the reference.